Health secretary seeks price cut for meningitis vaccine

Comments from Novartis suggest it may not give ground

Embryonic stem cells cloned from adults

Experiment could rekindle enthusiasm for therapeutic cloning

Charity tests new kind of drug trial

Cancer Research joins forces with pharmaceutical companies

Reckitt Benckiser eyes pharma spin-off

Group’s figures bolster ‘capital markets solution’ for RBP unit

Reckitt Benckiser eyeing pharma spin-off

Company’s strategic review highlights sale as ‘strong option’

Roche drug success counteracted by franc

Swiss currency’s strength hits pharmaceutical group’s revenues

Diamond’s adventure with BancABC

Precious Ramotswe cautions Diamond in his African adventure

UK stem cell blood set for human trials

Scheme seen as viable for patient tests by late 2016

GSK denies systemic corruption problem

BBC report says Polish doctors bribed to promote asthma drug

Race for hepatitis C drugs accelerates

Scramble for share of market expected to reach $20bn in sales

Big pharma: Storehouse of trouble

A raft of lawsuits and regulatory probes has given critics fresh ammunition

Europe and Asia join in US tech rout

French probe alleged drug collusion

Roche and Novartis investigated over lucrative eye treatment

Scientists hit out at UK flu expenditure

Government accused of throwing away more than £600m

Price of hepatitis C drug attacked

WHO condemns $1,000-a-day price of Gilead Sciences’ treatment

Actos case floors Takeda and Eli Lilly

Case highlights temptation to conceal potential health risks

Takeda: a fine mess

Drug companies prove resilient in the face of large fines

Johnson aims to boost life sciences

Record $6bn fine for Takeda over diabetes drug

Japan group hid possible link between product and bladder cancer

Doubts emerge about ‘wonder drugs’

Glitazones for diabetes run into safety issues


More FT Twitter accounts